Age : from 20 to 90 y/o.
HBsAg-positive for more than 6 months and HBV DNA < 2000 IU/ml (Subgroup 1)or HBsAg-negative but anti-HBc positive with HBV DNA < 2000 IU/ml (Subgroup 2).
Inflammatory arthritis patients who plan to treat with biological agents, including Humira or Enbrel or Simponi or Orencia or Mabthera or Actemra; as first line biologic treatment is indicated.

NCT01907230_inc_T1
Person
Age
NCT01907230_inc_T2
Value
20 to 90 y/o
NCT01907230_inc_T3
Measurement
HBsAg
NCT01907230_inc_T4
Value
positive
NCT01907230_inc_T5
Temporal
more than 6 months
NCT01907230_inc_T6
Measurement
HBV DNA
NCT01907230_inc_T7
Value
< 2000 IU/ml
NCT01907230_inc_T8
Measurement
HBsAg
NCT01907230_inc_T9
Value
negative
NCT01907230_inc_T10
Measurement
anti-HBc
NCT01907230_inc_T11
Value
positive
NCT01907230_inc_T12
Measurement
HBV DNA
NCT01907230_inc_T13
Value
< 2000 IU/ml
NCT01907230_inc_T14
Scope
HBsAg-positive for more than 6 months and HBV DNA < 2000 IU/ml
NCT01907230_inc_T15
Scope
Age : from 20 to 90 y/o. BsAg-positive for more than 6 months and HBV DNA < 2000 IU/ml (Subgroup 1)or HBsAg-negative but anti-HBc positive with HBV DNA < 2000 IU/ml
NCT01907230_inc_T16
Scope
HBsAg-negative but anti-HBc positive with HBV DNA < 2000 IU/ml
NCT01907230_inc_T17
Condition
Inflammatory arthritis
NCT01907230_inc_T18
Procedure
biological agents
NCT01907230_inc_T19
Drug
Humira
NCT01907230_inc_T20
Drug
Enbrel
NCT01907230_inc_T21
Drug
Simponi
NCT01907230_inc_T22
Drug
Orencia
NCT01907230_inc_T23
Drug
Mabthera
NCT01907230_inc_T24
Drug
Actemra
NCT01907230_inc_T25
Scope
Humira or Enbrel or Simponi or Orencia or Mabthera or Actemra